Results 131 to 140 of about 1,697 (149)

Corrigendum: Real-practice management and treatment of idiopathic multicentric Castleman disease with siltuximab: a collection of clinical experiences. [PDF]

Drugs Context
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Castleman disease

Nature Reviews Disease Primers, 2021
Antonino Carbone, Blossom A Damania, Annunziata Gloghini, Bs   +2 more
exaly  

Overview of Castleman disease

Blood, 2020
Angela Dispenzieri, David C Fajgenbaum
exaly  

Castleman's disease—a two compartment model of HHV8 infection

Nature Reviews Clinical Oncology, 2010
Klaus-Martin Schulte
exaly  

Idiopathic multicentric Castleman's disease: a systematic literature review

Lancet Haematology,the, 2016
Amy Y Liu, Christopher S Nabel, Brian S Finkelman   +2 more
exaly  

Prospective Study of Rituximab in Chemotherapy-Dependent Human Immunodeficiency Virus–Associated Multicentric Castleman's Disease: ANRS 117 CastlemaB Trial

Journal of Clinical Oncology, 2007
Laurence Gérard, Renaud Verdon, Eric Oksenhendler   +2 more
exaly  

HHV-8-negative, idiopathic multicentric Castleman disease: novel insights into biology, pathogenesis, and therapy

Blood, 2014
David C Fajgenbaum, Frits van Rhee, Christopher S Nabel   +2 more
exaly  

Surgery in Castleman's Disease

Annals of Surgery, 2012
Klaus-Martin Schulte
exaly  

Humanized anti–interleukin-6 receptor antibody treatment of multicentric Castleman disease

Blood, 2005
Tadamitsu Kishimoto
exaly